Hope for Zoledronic Acid in Breast Cancer?

Updated results for the ABCSG Trial 12 continue to show disease-free and overall survival benefits 2 years after stopping adjuvant endocrine treatment with zoledronic acid, Dr. Michael Gnant explains.

Updated results for the ABCSG Trial 12 continue to show disease-free and overall survival benefits 2 years after stopping adjuvant endocrine treatment with zoledronic acid, Dr. Michael Gnant explains.

Updated results for the ABCSG Trial 12 continue to show disease-free and overall survival benefits 2 years after stopping adjuvant endocrine treatment with zoledronic acid, Dr. Michael Gnant explains.